Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Diagnosis and treatment

Cleveland Clinic Journal of Medicine

Volumn 68, Issue 10, 2001, Pages 857-878

  George, James N ^a,b   Vesely, Sara K ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYCLOSPORIN; GEMCITABINE; GLUCOCORTICOID; IMMUNOGLOBULIN; MITOMYCIN C; PENTOSTATIN; QUININE; TICLOPIDINE; VINCRISTINE;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; MORTALITY; PATHOGENESIS; PLASMAPHERESIS; PREECLAMPSIA; REVIEW; SPLENECTOMY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

EID: 0034791991     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.68.10.857     Document Type: Review

References (46)

1. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature
2. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
3. Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic
4. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
5. Therapeutic plasma exchange: An update from the Canadian Apheresis Group
6. Management of thrombotic thrombocytopenic purpura
7. Thrombotic thrombocytopenic purpura: A paradigm shift?
8. Von Willebrand factor and thrombotic thrombocytopenic purpura
9. Thrombotic thrombocytopenic purpura: New insights in disease pathogenesis and therapy
10. Hemolytic-uremic syndrome, thrombotic thrombocytopenia purpura, and systemic sclerosis (systemic scleroderma)
11. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
12. Thrombotic thrombocytopenic purpura: A simpler diagnosis at last?
13. Thrombotic thrombocytopenic purpura: Outcome in 24 patients with renal impairment treated with plasma exchange
14. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura
15. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells
16. Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura
17. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
18. Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies
19. Thrombotic thrombocytopenic purpura report of 25 cases and review of the literature
20. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
21. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
22. The potential risks with future pregnancies after TTP-HUS
23. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): Frequency, clinical features, and long-term outcomes
24. Thrombotic thrombocytopenic purpura associated with ticlopidine - A review of 60 cases
25. Thrombotic thrombocytopenic purpura associated with clopidogrel
26. Occult quinine-induced thrombocytopenia
27. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura
28. Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry
29. Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak
30. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosis
31. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients
32. Thrombotic microangiopathy following bone marrow transplantation
33. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: An analysis of associated conditions and clinical outcomes
34. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention
35. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204)
36. Thrombotic microangiopathy and retroviral infections: A 13-year experience
37. Microangiopathic hemolytic anemia: The possible role of vascular lesions in pathogenesis
38. Acute respiratory distress syndrome as a major clinical manifestation of thrombotic thrombocytopenic purpura
39. Plasma exchange complications in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpurahemolytic uremic syndrome
40. Unintentional platelet removal by therapeutic plasmapheresis
41. Cryoprecipitate-poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)
42. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura
43. The potential risk of platelet transfusions in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS)
44. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery
45. Chronic thrombotic thrombocytopenic purpura masquerading as other disease entities
46. Medicine based evidence, a prerequisite for evidence based medicine